ROIV in the 13F filings
Roivant Sciences LTD · CUSIP G76279101
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 29
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 9 listed it in both
- Shares listed
- 103,573,085
- combined, among listed positions
- Reported value
- $2.2bn
- combined, at the quarter end
Among the 92 comparable managers: 16 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -12,365,899.
Managers listing ROIV in Q4 2025
29 of 29 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 65,779,464 shares now+5,012,480
- Janus Henderson Group Ltdexisting position · 2,918,109 shares now+2,775,331
- T. Rowe Price Associates Incexisting position · 5,335,125 shares now+2,414,629
- Citadel Advisors LLCexisting position · 2,286,001 shares now+1,317,798
- Man Group PLCexisting position · 1,457,127 shares now+972,973
Reductions
- Viking Global Investors LPexisting position · 6,443,191 shares now-17,151,640
- Jane Street Group LLCexisting position · 1,311,585 shares now-1,434,187
- Millennium Management LLCexisting position · 1,197,592 shares now-1,390,506
- Woodline Partners LPexisting position · 1,750,017 shares now-1,315,573
- Squarepoint Ops LLCexisting position · 516,955 shares now-916,074
New positions and exits
New (6)
Exited (3)
- Point72 Asset Management LPwas $39m
- ExodusPoint Capital Management LPwas $9.6m
- Schonfeld Strategic Advisors LLCwas $2.7m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2021 | 1 | $889m | n.a. | n.a. |
| Q1 2022 | 1 | $436m | n.a. | n.a. |
| Q2 2022 | 1 | $359m | n.a. | n.a. |
| Q3 2022 | 2 | $292m | n.a. | n.a. |
| Q4 2022 | 3 | $829m | n.a. | n.a. |
| Q1 2023 | 6 | $715m | n.a. | n.a. |
| Q2 2023 | 8 | $1.0bn | n.a. | n.a. |
| Q3 2023 | 8 | $1.7bn | n.a. | n.a. |
| Q4 2023 | 6 | $1.5bn | 2 | 5 |
| Q1 2024 | 6 | $912m | 2 | 2 |
| Q2 2024 | 8 | $1.4bn | 5 | 3 |
| Q3 2024 | 8 | $1.4bn | 6 | 2 |
| Q4 2024 | 8 | $1.3bn | 4 | 3 |
| Q1 2025 | 7 | $1.1bn | 4 | 2 |
| Q2 2025 | 9 | $1.2bn | 5 | 3 |
| Q3 2025 | 11 | $1.5bn | 5 | 5 |
| Q4 2025 | 14 | $1.9bn | 16 | 15 |
| Q1 2026 | 14 | $3.3bn | 18 | 15 |
| Q2 2026 | 15 | $4.5bn | 20 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ROIV and LLY →ROIV and JNJ →ROIV and VRTX →Choose a stock to compare with ROIV →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ROIV, latest filings →Back to the 13F Explorer →